March 2025

FDA announces new recall of Medtronic surgical devices over safety concerns ()
Cardiologists make case against routine interventions for asymptomatic severe AS ()
Plant-based diets may help patients with diabetes, heart disease live longer ()
First comprehensive T-TEER resource examines best practices for tricuspid valve repair ()
So far, so good: TAVR comparable to open heart surgery after 5 years in low-risk patients ()
Oral semaglutide reduces heart risks while helping patients move past ‘fear of the needle’ ()
‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes ()
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities ()
FDA chooses not to approve new nasal spray for heart rhythm issues ()
Challenges of Diagnosing CAD in Women ()
ACC urges RFK Jr. to make Medicare reform a priority, warns against mass layoffs ()
Strokes more likely for U.S. heart transplant recipients following policy change ()
Abbott gains CE mark approval for Volt PFA system ()
FDA sees promise in new AI model for heart attack detection ()
A glass of orange juice a day may help keep the cardiologist away ()
AHA still working to find more patients with severe aortic stenosis who may require care ()
Timing is everything: Delaying noncardiac surgery after a heart procedure reduces risks ()
The biggest names in TAVR are sharing new data at ACC.25 ()
Is statin therapy safe for pregnant women? ()
First-in-class SAVR valve from Edwards Lifesciences linked to positive 5-year outcomes ()
FDA approves vutrisiran to treat ATTR-CM ()
Abbott makes IVL move as FDA approves new clinical trial ()
Key trends in transcatheter tricuspid valve interventions ()
New drug shows early potential to treat aortic stenosis in some patients without TAVR, SAVR ()
New scanners and strategies for the ‘golden age of CCTA’ ()
Direct marketing to cardiologists increases uptake of some, but not all, heart failure drugs ()
How to address cardiologist burnout ()
CMS approves Medicare coverage for transcatheter tricuspid valve replacement ()
Safety update: FDA announces Class I recall due to atherectomy devices breaking during use ()
Choosing left radial access in the cath lab helps cardiologists limit radiation exposure ()
TAVR for failing surgical valves: Lessons learned from new 5-year data ()
Enabling X-ray-free ablation procedures in the EP lab ()
The evolution of RF technology to reduce complications and improve outcomes ()
Opportunistic screening: AI highlights key heart findings in mammography images ()
Electrophysiology Innovation at Texas Cardiac Arrhythmia Institute ()
Newborns with congenital heart defects face elevated cancer risk ()
Mitral valve repair vs. replacement: Surgeons track long-term outcomes in patients with infective endocarditis ()
Advances in bioresorbable stents show promise for treating PAD ()
Cannabis use increases risk of heart attack, stroke in young adults ()
The revolution is here: AI’s growing role in cardiovascular imaging, interventional cardiology ()
FDA clears first generic versions of rivaroxaban—what it means for patient care ()
SMART 2-year TAVR hemodynamic data: Medtronic Evolut is better compared to Edwards Sapien in small annulus patients ()
Bracco updates HeartSee coronary flow capacity software with new diagnostic features ()
American College of Cardiology shares new guidance focused on evaluation, management of cardiogenic shock ()
Woman says husband’s heart condition was misdiagnosed in wrongful death lawsuit ()
Abbott’s Amulet LAAO device linked to long-term safety, effectiveness ()
Food insecurity increases risk of poor heart health in young adults ()
TAVR or TAVI? Cardiologists want a single acronym for the popular heart procedure ()
AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs ()
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor ()
TAVR in Africa linked to high success rate, but above-average risks ()
Patient discharged with total artificial heart for first time—goes 105 days while awaiting transplant ()
Cardiologist arrested for allegedly sexually assaulting multiple colleagues ()
Tenecteplase compares favorably to alteplase in new comparison of FDA-approved stroke drugs ()
Fewer heart failure patients are dying from cardiac arrest—but disparities persist ()
Family files lawsuit after transplant ends in tragedy—says son ‘got the heart of a meth addict’ ()
Blood tests for signs of organ rejection made available for young heart transplant patients ()
FDA clears AI-assisted CCTA software that assesses plaques for signs of heart disease ()
Wellstar's CCTA + Heartflow Program Impact: Improving Patient Care While Driving Financial Growth ()
TAVR linked to stronger valve performance than SAVR in new 5-year study ()
Cardiology groups urge Congress to ‘take a stand’ after spending proposal fails to fix Medicare cuts ()
Self-expanding TAVR valves still linked to superior durability in patients with small annuli after 2 years ()
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension ()
Cardiologists agree: Early TAVR or SAVR for asymptomatic severe AS limits strokes, hospitalizations ()
SCAI leaders 'on a mission' to improve cath lab protection from radiation, orthopedic injury ()
‘A new alternative’: Tiny pacemakers for infants show early promise ()
Deadline extended: Nominate a young cardiology professional today ()
Cardiologists make history, complete world’s first robotic transcatheter mitral valve replacements ()
Building a successful CCTA program: Physicians and healthcare executives to share advice ()
FDA approves design updates for Perceval Plus surgical aortic valve ()
Cardiologists are first in world to use new TAVR catheter from Boston Scientific ()
FDA approves first new clot-dissolving drug for ischemic stroke in decades ()
TAVR vs. SAVR: Real-world data highlight advantages of both techniques ()
Cleerly and Bunkerhill Health unite in the name of AI-based cardiac imaging evaluations ()
Cardiologists treat first commercial patients with FDA-cleared valve-in-valve TAVR device ()
How AI and CCTA help heart teams plan ahead before PCI ()
Shockwave Medical launches new IVL catheter for targeting challenging lesions in PAD patients ()
Philips pulls endovascular devices from market after safety issues prompt Class I recall ()
Boston Scientific enters renal denervation market with acquisition worth up to $540M ()
Cardiologists recommend complete revascularization, intravascular imaging in new ACS guidelines ()